Funko Inc vs Johnson & Johnson — how do they compare? Funko Inc trades at $6.44 (market cap $363.97M), while Johnson & Johnson trades at $261.44 (market cap $618.09B). The key difference: Johnson & Johnson is far larger — about 1698.2× Funko Inc's market cap, and Johnson & Johnson pays a 2.09% dividend while Funko Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Funko Inc for 33 Days and Johnson & Johnson for 129 Days on average.
| FNKO | JNJ | |
|---|---|---|
Market Cap | $363.97M | $618.09B |
Volume | 1,422,651 | 6,050,983 |
Sector | Consumer Cyclical | Health |
52-Week High | $7.10 | $278.43 |
52-Week Low | $2.81 | $186.00 |
Typical Hold Time | 33 Days | 129 Days |
Enterprise Value | $584.62M | $646.37B |
Dividend Yield | — | 2.09% |
Signals from Pluang's Aura AI — not financial advice
Funko (FNKO) trades at $6.50, up 3.01% with strong technical momentum and bullish moving averages. The company shows improving fundamentals with recent earnings beats and raised EBITDA guidance, though profitability remains challenged with negative net margins. Analyst consensus leans Hold with a $7.58 price target, while institutional sentiment is mixed amid ongoing business transformation efforts.
Investment outlook balances technical strength against fundamental challenges. The stock offers potential upside to analyst targets but faces execution risks in maintaining recent operational improvements. Key catalysts include continued margin expansion and debt reduction, while risks include consumer discretionary spending pressures and competitive market positioning.
Johnson & Johnson (JNJ) trades at $256.48, down 0.76% on the day, with the stock showing mixed technical signals amid a bearish overall trend. The company maintains strong fundamentals with $94.19B in 2025 revenue, 21.48% net income margin, and consistent earnings beats in recent quarters. Recent analyst coverage shows 52.5% buy ratings with a $286.53 consensus price target, while technical indicators point to key support at $248 and resistance at $258.
JNJ presents a compelling long-term investment case with robust profitability, diversified healthcare portfolio, and dividend stability, though near-term headwinds include patent expirations and competitive pressures. The stock's current valuation at 29.75 P/E appears reasonable given strong cash flow generation and pipeline innovation, with upside potential to analyst targets if execution continues.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Funko Inc is a US-based pop culture consumer products company. It creates whimsical, fun, and different products which enable the customer to express their affinity for their favorite through movie, TV show, video game, musician or sports team. The company holds licenses and the rights to create tens of thousands of characters including Game of Thrones, Walking Dead, Disney, Marvel, Harry Potter, Fallout, and others. Its products include Pop, Dorbz, Mystery Vinyl, Plush, Action Figures, and Others. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites.
Read more on FNKO →Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →